SCHEMBL8915062

SCHEMBL8915062

O=P(c1ccccc1)(c1ccccc1)c1cccc(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 2/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ HPGD P15428 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ KCNK3 O14649 1/20 0.40
▸ CA2 P00918 1/20 0.39
▸ CA4 P22748 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31258324 0.93 CES2 (0.43) NFE2L2NPC1RAB9AHPGDMEN1
SCHEMBL778059 0.93 CES2 (0.43) NFE2L2NPC1RAB9AHPGDMEN1
SCHEMBL27780756 0.84 LMNA (0.42) LMNAMEN1KMT2ACA2CA4
SCHEMBL14020788 0.84 LMNA (0.48) RAB9ALMNAMEN1KMT2AKDM4E
SCHEMBL3181571 0.84 LMNA (0.48) RAB9ALMNAMEN1KMT2AKDM4E
SCHEMBL11991132 0.80 MEN1 (0.41) NFE2L2NPC1RAB9ALMNAMEN1
SCHEMBL10635216 0.79 LMNA (0.50) NFE2L2NPC1RAB9AHPGDLMNA
SCHEMBL1244527 0.79 LMNA (0.50) NFE2L2NPC1RAB9AHPGDLMNA
Triphenylphosphine Oxide SCHEMBL27649200 0.78 CA2 (0.52) LMNAMEN1KMT2ACA2CA4
Triphenylphosphine Oxide SCHEMBL3949 0.78 CA2 (0.58) LMNAMEN1KMT2ACA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102668156-B Organic electroluminescent device and novel alcohol solubility phosphorescent light-emitting materials DYDEN CORP. (JP) 2016-01-13 — — CN disclosed
US-20120261651-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL ALCOHOL-SOLUBLE PHOSPHORESCENT MATERIAL DAIDEN CO., LTD. (JP) 2012-10-18 — — US disclosed
US-20120261651-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL ALCOHOL-SOLUBLE PHOSPHORESCENT MATERIAL DAIDEN CO., LTD. (JP) 2012-10-18 — — US disclosed
US-20120261651-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL ALCOHOL-SOLUBLE PHOSPHORESCENT MATERIAL DAIDEN CO., LTD. (JP) 2012-10-18 — — US disclosed
US-5621128-A ENANTIOSELECTIVE CATALYSTS HOECHST AKTIENGESELLSCHAFT (DE) 1997-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120261651-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL ALCOHOL-SOLUBLE PHOSPHORESCENT MATERIAL SELENOI, L1CAM, ADH1C NFE2L2 2928/4885NPC1 2429/4885RAB9A 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback